Viewing Study NCT00228059


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-04 @ 9:49 AM
Study NCT ID: NCT00228059
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2005-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module